Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effects of the Combination of Spironolactone to Conventional Pharmacotherapy in Dialysis Patients

NCT01128101 is registered in ClinicalTrials.gov with UPECLIN HC FM Botucatu Unesp as lead sponsor.

NCT NCT01128101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01128101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effects of the Combination of Spironolactone to Conventional Pharmacotherapy in Dialysis Patients
Lead sponsor
UPECLIN HC FM Botucatu Unesp
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2011
Completion date
December 31, 2013
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure